resource shortage
FDA Misses IND Deadline for Coya’s ALS Asset, Citing Resource Constraints
FDA; Coya Therapeutics; IND application; ALS; clinical trial delay; COYA 302; resource shortage
Actionable Insights Powered by AI
FDA; Coya Therapeutics; IND application; ALS; clinical trial delay; COYA 302; resource shortage